Pharma Mar, S.A. (BME:PHM)
Spain
· Delayed Price · Currency is EUR 84.05
-7.85 (-8.54%)
Jun 6, 2025, 5:35 PM CET
Pharma Mar Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 6, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 1,615 | 1,389 | 738 | 1,158 | 1,033 | 1,313 | Upgrade
|
| Market Cap Growth | 181.50% | 88.09% | -36.23% | 12.13% | -21.36% | 66.27% | Upgrade
|
| Enterprise Value | 1,526 | 1,298 | 608 | 1,014 | 866 | 1,176 | Upgrade
|
| Last Close Price | 91.90 | 79.80 | 40.37 | 62.30 | 54.82 | 67.91 | Upgrade
|
| PE Ratio | 81.26 | 53.17 | 649.51 | 23.46 | 11.12 | 9.57 | Upgrade
|
| Forward PE | 32.30 | 36.29 | 67.76 | 16.74 | 12.76 | 10.53 | Upgrade
|
| PS Ratio | 9.19 | 7.94 | 4.67 | 5.90 | 4.49 | 4.87 | Upgrade
|
| PB Ratio | 8.18 | 6.67 | 3.82 | 5.19 | 5.81 | 12.78 | Upgrade
|
| P/TBV Ratio | 8.22 | 6.70 | 3.84 | 5.22 | 5.84 | 12.91 | Upgrade
|
| P/FCF Ratio | - | - | - | 39.30 | 57.78 | 4.76 | Upgrade
|
| P/OCF Ratio | - | 230.47 | - | 30.22 | 40.22 | 4.71 | Upgrade
|
| EV/Sales Ratio | 8.68 | 7.42 | 3.84 | 5.17 | 3.77 | 4.36 | Upgrade
|
| EV/EBITDA Ratio | 110.22 | 128.91 | - | 22.60 | 9.12 | 7.39 | Upgrade
|
| EV/EBIT Ratio | 198.68 | 200.70 | - | 24.11 | 9.37 | 7.51 | Upgrade
|
| EV/FCF Ratio | -85.78 | - | - | 34.42 | 48.46 | 4.26 | Upgrade
|
| Debt / Equity Ratio | 0.26 | 0.25 | 0.23 | 0.19 | 0.28 | 0.55 | Upgrade
|
| Debt / EBITDA Ratio | 3.75 | 4.19 | 48.68 | 0.91 | 0.51 | 0.35 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 1.45 | 2.76 | 0.21 | Upgrade
|
| Asset Turnover | 0.53 | 0.51 | 0.43 | 0.52 | 0.66 | 1.19 | Upgrade
|
| Inventory Turnover | 0.21 | 0.18 | 0.29 | 0.71 | 1.46 | 1.32 | Upgrade
|
| Quick Ratio | 2.23 | 2.29 | 1.98 | 2.18 | 2.93 | 2.31 | Upgrade
|
| Current Ratio | 2.97 | 3.03 | 2.63 | 2.83 | 3.42 | 2.59 | Upgrade
|
| Return on Equity (ROE) | 10.19% | 13.00% | 0.55% | 24.62% | 66.18% | 249.16% | Upgrade
|
| Return on Assets (ROA) | 1.44% | 1.17% | -0.65% | 6.91% | 16.54% | 43.04% | Upgrade
|
| Return on Capital (ROIC) | 1.99% | 1.63% | -0.95% | 10.67% | 29.89% | 77.41% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.00% | 2.40% | - | 14.20% | 32.80% | 66.60% | Upgrade
|
| Earnings Yield | 1.23% | 1.88% | 0.15% | 4.26% | 8.99% | 10.45% | Upgrade
|
| FCF Yield | -1.10% | -0.65% | -3.83% | 2.54% | 1.73% | 21.01% | Upgrade
|
| Dividend Yield | 0.87% | 1.00% | 1.61% | 1.04% | 1.19% | 0.88% | Upgrade
|
| Payout Ratio | 57.46% | 43.71% | 1028.06% | 23.83% | 11.71% | 6.42% | Upgrade
|
| Buyback Yield / Dilution | - | 1.98% | 0.81% | 0.12% | 1.31% | 0.77% | Upgrade
|
| Total Shareholder Return | 0.88% | 2.98% | 2.42% | 1.17% | 2.50% | 1.65% | Upgrade
|
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.